Florette K Hazard

4PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Florette K Hazard, Angus M S Toland, Serena Y Tan

|Sep 05, 2025
Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation.

Haowen Jiang, Sarah Jane Tiche, Clifford Jiajun He

|Dec 23, 2024
Restoring Mitochondrial Quantity and Quality to Reverse Warburg Effect and Drive Tumor Differentiation.

Jiangbin Ye, Haowen Jiang, Sarah Tiche

|Sep 13, 2023
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.

Courtney R Schott, Amanda L Koehne, Leanne C Sayles

Pageof 1